SHPH - Income Statement - Shuttle Pharmaceuticals Holdings, Inc.

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2018	Dec-2017
REVENUE
Revenue	0	0	0	0	0	0	0
GROSS PROFIT
Cost Of Revenue	0	6.81 K	66.8 K	60.8 K	55 K	18 K	18.7 K
Gross Profit	0	6.81 K	66.8 K	60.8 K	55 K	18 K	18.7 K
OPERATING INCOME
Operating Expenses	7.7	5.9	2.6	1.7	0.5	0.6	0.2
Selling, General and Administrative Expenses	1 392.7	1.0	1.1	0.7	0.3	0.5	0.2
Research and Development Expenses	3 618.8	3.5	1.5	1.0	0.2	55.6 K	836
Operating Income	(7 696.2)	(5.9)	(2.6)	(1.7)	(0.5)	(0.6)	(0.2)
PRE-TAX INCOME
Interest Income Expense	(8.7)	2.6	1.0	50.8 K	39.6 K	30.9 K	10.9 K
Total Other Income	(1 448.6)	(0.7)	(0.5)	0.6	(0.3)	39.5 K	9.7 K
Pre-Tax Income	(9 144.8)	(6.6)	(3.0)	(1.2)	(0.8)	(0.6)	(0.2)
NET INCOME
Tax Provision	0	0	71 K	50.8 K	39.6 K	0	1
Net Income	(9 144.8)	(6.6)	(3.1)	(1.2)	(0.8)	(0.6)	(0.2)
EPS	3.19 K	0.41	0.3	0.0885	0.0622	0.0461	0.0157

Free